Peptimimesis SAS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Peptimimesis SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11068
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Peptimimesis SAS (Peptimimesis) is a biopharmaceutical company that discovers and develops transmembrane therapeutic peptides. The company’s proprietary platform delivers a set of drug candidates that act on strategic targets in the field of immuno-oncology, oncology and immune diseases. Its proprietary technology helps in the detection of peptidomimetic candidates that affects the homodimerization and heterodimerization of target receptors. The company will develop products with its proprietary technology in partnership with pharmaceutical and biotechnology companies. Peptimimesis is headquartered in Strasbourg, France.

Peptimimesis SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Peptimimesis SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Peptimimesis SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Peptimimesis SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Peptimimesis SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Peptimimesis SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Peptimimesis SAS, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
PeptiMimesis Raises USD0.7 Million in Second Tranche of Seed Financing 10
PeptiMimesis Raises USD0.6 Million Financing 11
Partnerships 12
Ipsen Enters into Research Agreement with PeptiMimesis 12
Peptimimesis SAS – Key Competitors 13
Peptimimesis SAS – Key Employees 14
Peptimimesis SAS – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Peptimimesis SAS, Pharmaceuticals & Healthcare, Key Facts 2
Peptimimesis SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Peptimimesis SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Peptimimesis SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Peptimimesis SAS, Deals By Therapy Area, 2012 to YTD 2018 8
Peptimimesis SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
PeptiMimesis Raises USD0.7 Million in Second Tranche of Seed Financing 10
PeptiMimesis Raises USD0.6 Million Financing 11
Ipsen Enters into Research Agreement with PeptiMimesis 12
Peptimimesis SAS, Key Competitors 13
Peptimimesis SAS, Key Employees 14

List of Figures
Peptimimesis SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Peptimimesis SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Peptimimesis SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Peptimimesis SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Peptimimesis SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Peptimimesis SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Peptimimesis SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Peptimimesis SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Peptimimesis SAS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Drugs for Neglected Diseases initiative:製薬・医療:M&Aディール及び事業提携情報
    Summary Drugs for Neglected Diseases initiative (DNDi) is a non-profit drug research and development (R&D) organization which discovers and develops new drugs for neglected diseases. The organization develops therapeutics for the treatment of various diseases such as human African trypanosomiasis (H …
  • North China Pharmaceutical Co Ltd (600812):製薬・医療:M&Aディール及び事業提携情報
    Summary North China Pharmaceutical Co Ltd (NCPC), a subsidiary of North China Pharmaceutical Group Corp is a pharmaceutical company that develops, produces and sells novel drugs and pharmaceutical related products. The company offers preparation products, nutrition, pharmaceutical raw materials and …
  • Dart Container Corporation:企業の戦略・SWOT・財務情報
    Dart Container Corporation - Strategy, SWOT and Corporate Finance Report Summary Dart Container Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Alamo Group, Inc.:戦略・SWOT・企業財務分析
    Alamo Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Alamo Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • ALK-Abello AS (ALK B):企業の財務・戦略的SWOT分析
    ALK-Abello AS (ALK B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Team Health Holdings Inc-製薬・医療分野:企業M&A・提携分析
    Summary Team Health Holdings Inc (TeamHealth) is a healthcare organization that offers patient care services. The organization’s practice areas include emergency medicine, anesthesiology, hospital medicine, hospital medicine subspecialties, ambulatory care, post-acute care and behavioral health serv …
  • Conn’S, Inc.
    Conn'S, Inc. - Strategy, SWOT and Corporate Finance Report Summary Conn'S, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • MakeMyTrip Limited:企業のM&A・事業提携・投資動向
    MakeMyTrip Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's MakeMyTrip Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Jiangxi Copper Company Limited:戦略・SWOT・企業財務分析
    Jiangxi Copper Company Limited - Strategy, SWOT and Corporate Finance Report Summary Jiangxi Copper Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Harbin Electric International Co Ltd:企業の戦略的SWOT分析
    Harbin Electric International Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Automatic Data Processing, Inc.:企業の戦略・SWOT・財務情報
    Automatic Data Processing, Inc. - Strategy, SWOT and Corporate Finance Report Summary Automatic Data Processing, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Marenica Energy Ltd (MEY):企業の財務・戦略的SWOT分析
    Summary Marenica Energy Ltd (MEY) is a mining and mineral resource exploration and development company that acquires, identifies, develops, and explores for lead, silver, zinc, copper, uranium and gold mineral properties in Australia. The company develops and operates uranium project using conventio …
  • Cybernet Systems Corporation:企業の戦略・SWOT・財務情報
    Cybernet Systems Corporation - Strategy, SWOT and Corporate Finance Report Summary Cybernet Systems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • UniFirst Corp (UNF):企業の財務・戦略的SWOT分析
    UniFirst Corp (UNF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Blueknight Energy Partners LP:企業のM&A・事業提携・投資動向
    Blueknight Energy Partners LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Blueknight Energy Partners LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Shoal Point Energy Ltd (SHP):石油・ガス:M&Aディール及び事業提携情報
    Summary Shoal Point Energy Ltd (Shoal Point Energy) is an oil and gas exploration and development company that acquires, develops, explores, and produces petroleum products. The company holds interests in Green Point Oil-in-Shale and Humber Arm Shale project. It also holds interests in the explorati …
  • Bruce Power LP:企業の戦略的SWOT分析
    Bruce Power LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Koki Holdings Co Ltd:企業の戦略的SWOT分析
    Koki Holdings Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Techpool Bio-Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Techpool Bio-Pharma Co Ltd (Techpool Bio-Pharma) is a biopharmaceutical company. The company manufactures urinary protein biopharmaceuticals in critical care conditions. The company’s products include ulinastatin for injection, urinary kallidinogenase for injection, urokinase for injection a …
  • Biotest AG (BIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Biotest AG (Biotest) provides pharmaceutical and biotherapeutic drugs. It develops, manufactures and distributes biological medicines through its value chain from preclinical and clinical development to sales. Its main products comprise clotting factors, immunoglobulins, albumin and monoclon …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆